Plexus (NASDAQ:PLXS) Releases Q2 2025 Earnings Guidance

Plexus (NASDAQ:PLXS) issued an update on its second quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 1.460-1.610 for the period, compared to the consensus earnings per share estimate of 1.610. The company issued revenue guidance of $960.0 million-$1.0 billion, compared to the consensus revenue estimate of $1.0 billion.

Plexus Stock Up 0.1 %

Plexus stock traded up $0.17 during trading on Wednesday, hitting $170.49. 273,613 shares of the company were exchanged, compared to its average volume of 153,134. The business’s 50 day moving average is $162.01 and its 200 day moving average is $141.04. Plexus has a 52 week low of $90.18 and a 52 week high of $172.89. The company has a market capitalization of $4.62 billion, a P/E ratio of 42.52 and a beta of 0.91. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 9.51% and a net margin of 2.82%. Analysts predict that Plexus will post 6.13 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on PLXS. Benchmark raised their price target on Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a report on Monday, October 28th. KeyCorp assumed coverage on Plexus in a report on Tuesday, October 22nd. They issued a “sector weight” rating on the stock. Needham & Company LLC increased their price objective on Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a research report on Friday, October 25th. Stifel Nicolaus increased their price objective on Plexus from $136.00 to $150.00 and gave the company a “hold” rating in a research report on Tuesday, December 10th. Finally, StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Plexus has a consensus rating of “Moderate Buy” and a consensus target price of $159.00.

Insider Buying and Selling

In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the sale, the chief executive officer now owns 74,271 shares in the company, valued at approximately $11,615,241.69. This trade represents a 1.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Patrick John Jermain sold 5,045 shares of the stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $143.13, for a total value of $722,090.85. Following the completion of the sale, the chief financial officer now owns 24,602 shares of the company’s stock, valued at approximately $3,521,284.26. This trade represents a 17.02 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 34,091 shares of company stock worth $5,377,960 in the last ninety days. 1.76% of the stock is owned by insiders.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.